Northwestern University researchers have identified structural features in engineered cell receptors that correlate with ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

The discovery of a new bat coronavirus in China has sparked concerns of another pandemic. The virus, HKU5-CoV-2, is similar ...

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...

Investigators at the Jacobs School of Medicine and Biomedical Sciences have uncovered how heat causes a critical receptor protein within cells to unfold and relay pain, which could open up new ...

The virus is related to the pathogen that causes Middle East respiratory syndrome and capitalizes on the same ‘entry receptor ...

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.

A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...

The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker ...

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

Anti-acetylcholine receptor antibody (AChR-Ab) titers and the AChR-Ab rates of change correlated with myasthenia gravis ...